Our stringent standards
guarantee premium service.
The lab - Advanced Testing in Clinical Genetics (ACTG)is a CLIA and CAP certified genetic laboratory located in Irvine, California.
All tests are performed utilizing Thermo Fisher open array technology
The collection process is simple and noninvasive collection of cells from the inside of your cheeks. Utilizing the provided polyester swabs, rub the inside of both sides of your cheek for approximately 10 seconds
MYCBD is a simple, painless, non-invasive human genetic test analyzing the sixteen (16) most prominent endocannabinoid receptors in the human body. The majority of prescription pain medications are designed to treat Pain, Anxiety, and Insomnia, the identical primary indications for CBD use. However working adults and the elderly struggle with the mood altering effects of Prescription Pain Medications and THC. The literature supports working adults and the elderly would prefer to treat their pain, anxiety and insomnia holistically, and with CBD. MYCBD bridges the gap between the medical community and the medicinal cannabis space. Our personalized Endocannabinoid testing objectively details your genetic CNR1 and CNR2 endocannabinoid profile. This profile can then be used by both physicians and medical marijuana dispensaries to determine your likely success with CBD based therapies.
Coincidentally, the primary indications for CBD use are identical for the primary indications for prescription pain medications: Pain, Anxiety, and Insomnia.
Because there is such a profound overlap between Pain Patients and CBD Customers, MYCBD uniquely analyzes each individuals CNR receptor makeup. And based on each patient's particular expression of those CNR receptors, MYCBD ranks a patients likely success with CBD based medications as they look for alternatives to prescription pain medications.
MYCBD is unique. We give the patient and the medical provider critically important clinical information. We objectively determine if a patient is a strong candidate for Medical Cannabis use. Then we take it a step further. Through our IRB approved clinical studies in Hospitals and Urgent Care centers we will be able to provide a medical provider, patient and ultimately the budtenders that have no medical/pharmaceutical training disease specific recommendations for both CBD and Marijuana strain and concentration profiles.